Clinical Trials Insight: 700049152

Next Previous
Trial Profile

Clinical Trials Insight: 700049152

Planning
Phase of Trial: Phase I

Latest Information Update: 25 Sep 2009

At a glance

  • Drugs Retigabine (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Valeant Pharmaceuticals International

    • Most Recent Events

    • 25 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top